Nordson Corporation research snapshot
NDSN AI stock analysis currently reads Nordson Corporation as a high-quality precision dispensing, fluid management, medical components, test, inspection, and industrial technology company. At the July 8, 2026 data cutoff, NDSN closed at $286.03 on July 7, and market cap math verified about $15.94 billion using 55.72 million shares outstanding. The business benefits from application know-how, customer process integration, high EBITDA margins, long dividend history, and improving fiscal 2026 order trends. The caution is price discipline: the stock trades near 30.6x GAAP TTM EPS and 22.5x free cash flow per share, so the NDSN AI stock forecast needs continued backlog conversion, margin execution, and a still-premium industrial multiple to work. This is informational research and not investment advice.
Current price
$286.03
Market cap
$15.94 billion verified market cap
AI score
72 / 100
Rating
High-quality precision technology compounder with strong margins, backlog recovery, and valuation sensitivity
Trend status
Near the 50-day average and above the 200-day average, with neutral RSI after a pullback from the June 2026 high
Data cutoff (updated weekly)
July 8, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Nordson sells precision dispensing, coating, polymer processing, medical fluid components, electronics dispense, test, inspection, and related systems used in mission-critical manufacturing processes. | High |
| Moat | The moat comes from application engineering, process know-how, installed systems, qualified medical and electronics workflows, customer switching friction, and service relationships in niche production steps. | Medium-high |
| Management | CEO Sundaram Nagarajan has led Nordson since 2019 and runs the Ascend strategy, using segment focus, margin discipline, acquisitions, divestitures, dividends, and buybacks to shape the portfolio. | Medium-high |
| Financial trend | Fiscal 2025 sales were $2.79 billion, net income was about $484 million, adjusted EPS was $10.24, and Q2 fiscal 2026 sales rose 8% to a second-quarter record of $741 million. | High |
| Valuation | At $286.03, audited math shows about 30.6x GAAP TTM EPS, 26.0x adjusted TTM EPS, 5.0x book value, 22.5x free cash flow per share, 5.7x sales, and a 1.15% dividend yield. | High |
| Technical trend | NDSN sits near its 50-day moving average around $287 and above its 200-day moving average around $263, with RSI near 45 after a July pullback. | Medium-high |
| Risk level | Risk is moderate because the company is high quality but exposed to industrial orders, medical component demand, electronics systems shipments, acquisition execution, leverage, and premium multiple risk. | Medium-high |
| AI confidence | Descriptive data confidence is high because filings, company releases, and third-party datasets align closely on key figures. Return confidence is lower because the next outcome depends on orders, margins, and valuation. | High data confidence |
| Investment certainty | NDSN screens as a durable industrial technology franchise at a demanding but not extreme valuation. Certainty improves if backlog converts into organic growth without margin erosion. | Medium |
NDSN AI stock forecast
The NDSN AI stock forecast uses the $286.03 price reference, adjusted TTM EPS near $10.99, and a three-year earnings multiple framework. The audited model produced a bearish value near $186, a base value near $327, and a bullish value near $468. These are scenario ranges, not price promises.
$455 to $475
More likely if fiscal 2026 guidance is met or raised again, backlog growth converts to organic sales, Medical and Fluid Solutions keeps compounding, Advanced Technology Solutions recovers, free cash flow conversion stays high, debt falls, and investors keep valuing NDSN near a low-30s earnings multiple.
$315 to $335
More likely if sales grow in the mid single digits, adjusted EPS compounds near 6% annually, margins remain near historical quality levels, acquisitions add modestly, and the market applies a mid-20s earnings multiple.
$180 to $195
More likely if electronics test and polymer systems weaken, medical customer destocking returns, acquisitions disappoint, leverage limits buybacks, or the stock is re-rated toward a high-teens earnings multiple.
NDSN AI technical analysis
NDSN AI technical analysis uses market and technical data available at the July 8, 2026 cutoff. MarketWatch reported a July 7, 2026 close of $286.03 after a 2.60% decline. StockAnalysis reported the 50-day moving average near $286.99, the 200-day moving average near $263.07, RSI near 44.96, beta near 0.97, and 20-day average volume near 460,281 shares.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $286.03 | July 7, 2026 closing price reference used for market cap verification. |
| Immediate support | $280 to $286 | This band covers the July pullback and the 50-day moving average area. Buyers need to defend it to keep the short-term base intact. |
| Intermediate support | $263 to $266 | The 200-day moving average sits near this zone and is the main long-term trend reference for this static page. |
| Near resistance | $294 to $300 | This zone covers the July 6 close and the first rebound area after the July 7 decline. |
| Breakout reference | $307 to $308 | MarketWatch reported a 52-week high of $307.74 on June 25, 2026. |
| Momentum | RSI near 45 | RSI is neutral to soft, so the setup needs price confirmation rather than assuming a durable breakout. |
| Volume | 275,934 shares on July 7 | MarketWatch reported July 7 volume below the 50-day average, so a rebound above resistance would need stronger participation. |
| Volatility | Beta near 0.97 | NDSN usually moves close to market beta, but earnings, guidance, acquisitions, and industrial order data can create company-specific swings. |
| Invalidation | Close below $280, then $263 | A close below $280 would weaken the near-term setup. A break below the 200-day average near $263 would signal a larger trend failure. |
NDSN AI trading strategy
The NDSN AI trading strategy below is a rules-based research framework, not personal advice. It connects chart levels with fiscal 2026 guidance, backlog growth, segment sales, margin quality, cash generation, debt, dividend policy, acquisition execution, and valuation risk.
Watch for NDSN to hold the $280 to $286 support band, reclaim $294 to $300, and then challenge the $307 to $308 breakout reference while Q3 results confirm backlog conversion and margin durability.
A close below $280, weaker order commentary, or fiscal 2026 guidance reduction should reduce trend-following confidence.
If NDSN pulls back toward the 200-day moving average without a thesis break, compare the entry price with base-case value, adjusted EPS durability, free cash flow conversion, debt progress, and segment mix.
Do not treat a lower price as automatically cheap. Multiple compression can offset solid execution when a high-quality industrial stock starts from a premium valuation.
Track organic sales growth, backlog, Industrial Precision Solutions, Medical and Fluid Solutions, Advanced Technology Solutions, EBITDA margin, adjusted EPS, free cash flow, total debt, buybacks, and dividend increases.
Reduce confidence if growth relies mainly on price, acquisitions, or temporary backlog while organic orders, medical demand, electronics systems, or cash conversion weaken.
Investment research summary
Customers pay Nordson because production processes in adhesives, coatings, polymers, medical devices, electronics, semiconductors, packaging, and precision agriculture need accurate dispensing, fluid control, inspection, and process reliability.
The moat is built from application engineering, process qualification, trusted uptime, service support, installed equipment, medical and electronics validation, niche product breadth, and the cost of disrupting a working manufacturing line.
The thesis fails if industrial demand slows, electronics test shipments remain lumpy, medical customers destock, acquisition integration consumes capital, lower-cost competitors narrow performance gaps, or the market stops paying a premium for niche industrial quality.
Sundaram Nagarajan brought a long ITW operating background and has emphasized the Ascend strategy, portfolio discipline, margin quality, cash generation, acquisitions, divestitures, buybacks, and dividends. The test is whether capital allocation keeps compounding per-share value.
Nordson benefits from automation, miniaturization, medical device complexity, electronics packaging, semiconductor process control, precision agriculture, and demand for higher-yield manufacturing. These trends are favorable, but order timing remains cyclical.
At $286.03, NDSN is priced as a quality compounder rather than a distressed cyclical. Margin of safety depends on backlog conversion, organic growth, high free cash flow conversion, lower leverage, and avoiding a reset from roughly 31x GAAP TTM earnings.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| NDSN quote reference | $286.03 closing price on July 7, 2026 | MarketWatch daily market report | July 8, 2026 |
| Market capitalization verification | $15.94 billion calculated from $286.03 x 55.72 million shares, with 0.02% variance versus reported market cap | Pineify financial_rigor.py and StockAnalysis | July 8, 2026 |
| Shares outstanding | 55.72 million shares outstanding | StockAnalysis NDSN statistics | July 8, 2026 |
| Fiscal 2025 revenue | $2.7917 billion, cross-validated with Macrotrends and StockAnalysis within 0.01% | Nordson FY2025 results release | July 8, 2026 |
| Fiscal 2025 net income | $484.47 million, cross-validated with the annual report and StockAnalysis within 0.10% | Nordson 2025 annual report | July 8, 2026 |
| Q2 fiscal 2026 results | $740.8 million sales, $117 million net income, $2.09 GAAP diluted EPS, $2.86 adjusted diluted EPS, and backlog up 18% year over year | Nordson Q2 fiscal 2026 results release | July 8, 2026 |
| Fiscal 2026 guidance | Sales growth expected at 5% to 8% and adjusted EPS growth expected at 10% to 15% | Nordson FY2026 Q2 investor presentation | July 8, 2026 |
| Cash and debt | Cash sources differ by date: FY2025 cash was $108.4 million, while 2026 MRQ sources are near $103.1 million. Yahoo Finance reported total debt near $1.97 billion. | Nordson FY2025 results, Yahoo Finance, and Simply Wall St | July 8, 2026 |
| Valuation math | 30.56x GAAP TTM EPS, 4.98x book value, 22.50x free cash flow per share, 5.71x sales, and 1.15% dividend yield | Pineify financial_rigor.py valuation verification | July 8, 2026 |
| Technical indicators | 50-day moving average near $286.99, 200-day moving average near $263.07, RSI near 44.96, beta near 0.97, and 20-day average volume near 460,281 | StockAnalysis NDSN statistics | July 8, 2026 |
| Dividend reference | $0.82 quarterly dividend in fiscal 2026 and $3.28 annualized dividend rate | Nordson dividend history and MarketBeat dividend data | July 8, 2026 |
| Management | Sundaram Nagarajan has served as President and CEO since August 2019 after a 23-year career at Illinois Tool Works | Nordson executive management page | July 8, 2026 |
This NDSN AI stock analysis is an informational research tool only. It is not investment advice, financial advice, a recommendation to buy or sell Nordson Corporation, or a personalized trading plan. Forecast ranges are scenario outputs based on available data and assumptions as of July 8, 2026, and they can be wrong.
